Legend Biotech (LEGN) Equity Ratio (2019 - 2025)
Historic Equity Ratio for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to 0.59.
- Legend Biotech's Equity Ratio fell 818.39% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year decrease of 818.39%. This contributed to the annual value of 0.62 for FY2024, which is 796.27% down from last year.
- Per Legend Biotech's latest filing, its Equity Ratio stood at 0.59 for Q3 2025, which was down 818.39% from 0.61 recorded in Q2 2025.
- Over the past 5 years, Legend Biotech's Equity Ratio peaked at 0.73 during Q2 2023, and registered a low of 0.0 during Q1 2021.
- For the 5-year period, Legend Biotech's Equity Ratio averaged around 0.55, with its median value being 0.63 (2025).
- Per our database at Business Quant, Legend Biotech's Equity Ratio plummeted by 2513.76% in 2021 and then skyrocketed by 21153178854.81% in 2022.
- Over the past 5 years, Legend Biotech's Equity Ratio (Quarter) stood at 0.68 in 2021, then decreased by 18.27% to 0.56 in 2022, then rose by 21.05% to 0.68 in 2023, then dropped by 7.96% to 0.62 in 2024, then fell by 5.24% to 0.59 in 2025.
- Its Equity Ratio stands at 0.59 for Q3 2025, versus 0.61 for Q2 2025 and 0.63 for Q1 2025.